Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Detection Rate of Integrated Molecular and Cytogenetic Biomarker Testing for Chronic Lymphocytic Leukemia

Ramadevi Prathapam, Najuma Maharjan, Sheila B Powers, Tracey Allen K Freitas, Guoli Sun, Zheng Tan, Saurabh K Gupta, Vishwanathan Hucthagowder, Jennifer A Graham, Stacey L Whitman, Sushant Khadgi, Sugganth Daniel, Frederick K. Racke, Kristen J Champion

Blood (2021) 138 (Supplement 1): 4691.

https://doi.org/10.1182/blood-2021-152717

Published: 2021

Journal Articles

Unrecognized Clonal Hematopoiesis of Indeterminate Potential in Solid Tumors: Implications for Interpretation of Molecular Testing

Eric A Severson, MD PhD MMSc, Caitlin F Connelly, PhD, Shakti Ramkissoon, MD PhD, Garrett M Frampton, PhD, Laurie M Gay, PhD, Sugganth Daniel, MD, Julia A Elvin, MD PhD, James Suh, MD, Vincent A Miller, MD, Philip J Stephens, PhD, Siraj M Ali, MD PhD, Jeffrey S Ross, MD, Jo-Anne Vergilio, MD

Blood (2017) 130 (Supplement 1): 115.

https://doi.org/10.1182/blood.V130.Suppl_1.115.115

Published: 2017

Journal Articles

Comprehensive Genomic Profiling Demonstrates Differences in Primary CNS Lymphoma and Systemic Diffuse Large B Cell Lymphoma and Reveals Biomarkers Indicating Potential Benefit from Immune Checkpoint Inhibitors

Eric A Severson, MD PhD MMSc, Jo-Anne Vergilio, MD, Laurie M Gay, PhD, Sugganth Daniel, MD, Julia A Elvin, MD PhD, James Suh, MD, Vincent A Miller, MD, Philip J Stephens, PhD, Jeffrey S Ross, MD, Shakti Ramkissoon, MD PhD

Blood (2017) 130 (Supplement 1): 3996.

https://doi.org/10.1182/blood.V130.Suppl_1.3996.3996

Published: 2017

Journal Articles

Comprehensive Genomic Profiling Identifies Genomic Alterations That Define Philadelphia-like B-Acute Lymphoblastic Leukemia

Eric A Severson, MD PhD MMSc, Laurie M Gay, PhD, Sugganth Daniel, MD, Julia A Elvin, MD PhD, James Suh, MD, Michelle Nahas, PhD, Vincent A Miller, MD, Philip J Stephens, PhD, Jeffrey S Ross, MD, Shakti Ramkissoon, MD PhD, Jo-Anne Vergilio, MD

Blood (2017) 130 (Supplement 1): 476.

https://doi.org/10.1182/blood.V130.Suppl_1.476.476

Published: 2017

Journal Articles

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Jo-Anne Vergilio, MD, Laurie M Gay, PhD, Lei Zhong, PhD, Mark Rosenzweig, PhD, Yakov Chudnovsky, PhD, Jie He, PhD, Michelle Nahas, PhD, Siraj M Ali, MD PhD, Sugganth Daniel, MD, Shakti Ramkissoon, MD PhD, James Suh, MD, Julia A Elvin, MD PhD, Tariq I Mughal, MD FRCP, Philip J Stephens, PhD, Vincent A Miller, MD, Rachel Erlich, PhD, Jeffrey S Ross, MD, Eric A Severson, MD PhD MMSc, Samantha Morley, PhD

Blood (2017) 130 (Supplement 1): 417.

https://doi.org/10.1182/blood.V130.Suppl_1.417.417

Published: 2017

NARROW

Detection Rate of Integrated Molecular and Cytogenetic Biomarker Testing for Chronic Lymphocytic Leukemia

Unrecognized Clonal Hematopoiesis of Indeterminate Potential in Solid Tumors: Implications for Interpretation of Molecular Testing

Comprehensive Genomic Profiling Demonstrates Differences in Primary CNS Lymphoma and Systemic Diffuse Large B Cell Lymphoma and Reveals Biomarkers Indicating Potential Benefit from Immune Checkpoint Inhibitors

Comprehensive Genomic Profiling Identifies Genomic Alterations That Define Philadelphia-like B-Acute Lymphoblastic Leukemia

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Email alerts

ASH Publications

American Society of Hematology

Detection Rate of Integrated Molecular and Cytogenetic Biomarker Testing for Chronic Lymphocytic Leukemia

Unrecognized Clonal Hematopoiesis of Indeterminate Potential in Solid Tumors: Implications for Interpretation of Molecular Testing

Comprehensive Genomic Profiling Demonstrates Differences in Primary CNS Lymphoma and Systemic Diffuse Large B Cell Lymphoma and Reveals Biomarkers Indicating Potential Benefit from Immune Checkpoint Inhibitors

Comprehensive Genomic Profiling Identifies Genomic Alterations That Define Philadelphia-like B-Acute Lymphoblastic Leukemia

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only